Adquisición de habilidades motrices acuáticas en niños de 3 a 11 años

Existe cierta controversia acerca de la adquisición de habilidades motrices acuáticas en niños. Ello conlleva a la necesidad de concretar la edad adecuada para comenzar el aprendizaje. El objetivo del estudio fue evaluar la adquisición de habilidades motrices acuáticas de propulsión, respiración y flotación en niños en función de la edad. 337 alumnos de edades comprendidas entre los 3 y los 11 años fueron evaluados a través de un test ad hoc. Se presenta innovación en la adquisición de las habilidades motrices acuáticas en función de la edad. La mayoría de las variables presentaron una asociación significativa con la edad. Sólo las variables “Flotación estático vertical” (p=0,06), “Propulsión ventral de brazos alternos” (p=0,23), “Propulsión ventral de piernas alternas” (p=0,71), “Propulsión ventral de brazos y piernas alternos” (p=0,07) y “Propulsión dorsal de piernas alternas” (p=0,08) no presentaron una asociación con la edad. Los resultados señalan la necesidad de seguir una evolución proporcional en la metodología de enseñanza en función de la edad, prestando especial interés en las habilidades de propulsión, las cuales requieren un componente coordinativo simultáneo. A modo de conclusión, la adquisición de habilidades motrices acuáticas en niños de 3 a 11 años sigue una evolución motriz acorde a la edad.

Outpatient follow-up during the first year after heart transplantation, is it feasible?

First year follow-up after heart transplantation requires invasive tests. Although patients used to be hospitalized for this purpose, ambulatory invasive procedures now offer the possibility of outpatient follow-up. The feasibility and security of this strategy is unknown. From 2007 we transitioned to outpatient follow-up. We have retrospectively reviewed the clinical course of the outpatient group (2007 to 2014) and an inpatient group (2000–2006). Basal characteristics, hospital stay, infections, rejection episodes and vascular complications were evaluated. 87 patients had Inpatient Follow-up (IF) and 98 Outpatient Follow-up (OF). Basal characteristics were similar, with significant differences in immunosuppression (tacrolimus IF 44.8% vs. OF 90.8%, and mycophenolate IF 86.2% vs OF 100%, both p values < 0.001) and age (IF 52 ± 11.5 years vs. OF 56.1 ± 11 years, p = 0.016). In the OF group more clinical visits were performed (IF 10 vs. OF 13, p < 0.001) while hospital stay was lower (IF 23 days vs. OF 3 days, p < 0.001). The rate of infection, rejection, and vascular complications was similar. No difference was found in 1-year mortality (IF 2.3% vs. 1.0%, p = 0.60). First year post-cardiac transplantation outpatient follow-up seems to be feasible and safe in terms of infection, rejection, vascular complications and mortality.

Outpatient follow-up during the first year after heart transplantation, is it feasible?

First year follow-up after heart transplantation requires invasive tests. Although patients used to be hospitalized for this purpose, ambulatory invasive procedures now offer the possibility of outpatient follow-up. The feasibility and security of this strategy is unknown. From 2007 we transitioned to outpatient follow-up. We have retrospectively reviewed the clinical course of the outpatient group (2007 to 2014) and an inpatient group (2000–2006). Basal characteristics, hospital stay, infections, rejection episodes and vascular complications were evaluated. 87 patients had Inpatient Follow-up (IF) and 98 Outpatient Follow-up (OF). Basal characteristics were similar, with significant differences in immunosuppression (tacrolimus IF 44.8% vs. OF 90.8%, and mycophenolate IF 86.2% vs OF 100%, both p values < 0.001) and age (IF 52 ± 11.5 years vs. OF 56.1 ± 11 years, p = 0.016). In the OF group more clinical visits were performed (IF 10 vs. OF 13, p < 0.001) while hospital stay was lower (IF 23 days vs. OF 3 days, p < 0.001). The rate of infection, rejection, and vascular complications was similar. No difference was found in 1-year mortality (IF 2.3% vs. 1.0%, p = 0.60). First year post-cardiac transplantation outpatient follow-up seems to be feasible and safe in terms of infection, rejection, vascular complications and mortality.